Figure 5From: Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinomaSurvival analysis of prognostic factors of patients with FLC. Patients who underwent surgical treatment (n = 10, median survival of 60 ± 10 months) vs patients with medical treatment only (n = 5, median survival of 5 ± 2 months), p = 0.0011.Back to article page